Bio/Pharma News

Aug 14, 2018
By Pharmaceutical Technology Editors
Pharmaceutical scientist association announces upcoming term’s board of directors.
Aug 13, 2018
By Pharmaceutical Technology Editors
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
Aug 08, 2018
By Pharmaceutical Technology Editors
Denmark-headquartered pharmaceutical company LEO Pharma is set to acquire Bayer’s prescription treatment portfolio.
Aug 07, 2018
By Pharmaceutical Technology Editors
The European Commission (EC) approved Pfizer’s Trazimera (trastuzumab), a biosimilar to Roche’s Herceptin, to treat certain breast and gastric cancers.
Aug 06, 2018
By Pharmaceutical Technology Editors
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
Aug 06, 2018
By Pharmaceutical Technology Editors
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
Aug 03, 2018
By Pharmaceutical Technology Editors
AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material.
Aug 02, 2018
By Pharmaceutical Technology Editors
The company broke ground on its $200-million, 120,000-sq-ft biomanufacturing plant in West Greenwich, RI.
Aug 02, 2018
By Pharmaceutical Technology Editors
Stem-cell developer TiGenix has been acquired by Takeda Pharmaceutical for approximately EUR 520 million (US$604 million).
Aug 01, 2018
By Pharmaceutical Technology Editors
The companies will work together to develop novel gamma delta T-cell receptor therapies in various cancers.
native1_300x100
lorem ipsum